Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haematopoietic stem cell ageing.

A Globerson1

  • 1Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Novartis Foundation Symposium
|March 31, 2001
PubMed
Summary
This summary is machine-generated.

Haematopoietic stem cells maintain basic function but lose stress resilience with age. Understanding ageing mechanisms is key for stem cell therapies like transplantation and gene therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular ageing in vitro.

Cytotechnology·2012
Same author

Reactivation in vitro of immunocompetence in irradiated mouse spleen.

The Journal of experimental medicine·2009
Same author

Evidence-based roads to the promotion of health in old age.

The journal of nutrition, health & aging·2008
Same author

Geriatric health care to the elderly in Israel.

Archives of gerontology and geriatrics. Supplement·2004
Same author

The center for multidisciplinary research in aging (CMRA) at Ben Gurion University of the Negev in Israel.

Experimental gerontology·2001
Same author

Biogerontology research in Israel.

Experimental gerontology·2001
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

Area of Science:

  • Gerontology
  • Hematology
  • Stem Cell Biology

Background:

  • The aging of hematopoietic stem cells (HSCs) is a controversial topic with renewed interest due to stem cell applications in transplantation and gene therapy.
  • Research has focused on HSCs' ability to generate blood cells and self-renew, crucial properties for their function.

Purpose of the Study:

  • To evaluate the impact of aging on HSC function, including self-renewal and stress response.
  • To assess the feasibility of using aged HSCs for autologous transplantation and the challenges in T cell development.
  • To explore the potential risks of replicative senescence and developmental changes in HSCs during in vitro expansion.

Main Methods:

  • Analysis of HSC properties, including blood cell generation and self-renewal capacity.

Related Experiment Videos

  • In vitro expansion and maintenance of stem cells to examine long-term function.
  • Evaluation of age-related changes in T cell development and lymphoid differentiation.

    • Main Results:

    • Basal hematopoiesis is maintained throughout life, but the capacity to handle hematological stress diminishes with age.
    • Aged HSCs may be suitable for autologous transplantation to restore basic hematopoiesis.
    • Age-related alterations in T cell development necessitate further investigation for potential interventions.

    Conclusions:

    • While basic hematopoietic function persists, the stress response of HSCs declines with age.
    • Understanding the mechanisms of HSC aging, including replication, migration, and differentiation, is crucial for optimizing stem cell therapies.
    • Further research is needed to address age-related changes in T cell development for enhanced therapeutic outcomes.